Madalyn Neff

About Madalyn Neff

This author has not yet filled in any details.
So far Madalyn Neff has created 33 blog entries.

[Guest Post] Helping More Patients Take Advantage of FDA’s Expanded Access Program

In February 2012, Kaiba Gionfriddo became the first infant to receive an experimental 3D-printed airway/tracheal splint that opened his airways and saved his life. Nineteen additional young patients have since been implanted with the device, which was developed by researchers at the University of Michigan and provided to the patients under the Food and Drug […]

2019-05-07T08:32:26-04:00May 7, 2019|General|

[Blog Post] Join Us in Targeting Disparities

April is National Minority Health Month, and Clinical Research Pathways joins the U.S. Department of Health and Human Services Office of Minority Health (OMH) and organizations nationwide in raising awareness of—and working to address—health disparities that affect racial and ethnic minorities in the U.S.

Despite advances in treatment, many chronic conditions still are more likely to […]

2019-04-22T16:45:15-04:00April 22, 2019|General|

[Guest Post] Called to Serve in a Different Way

Until recently, most of my work on health equity was as part of a team on the ground. We reached out to members of the minority community, encouraging them to take advantage of available healthcare services, educating them about the importance of clinical trials, and enrolling them in research studies, […]

2019-04-02T09:14:51-04:00March 30, 2019|General|

[Scientific Journal Article] Executive Director Marjorie A. Speers, Ph.D., Discusses Advantages and Disadvantages of Clinical Trials and Expanded Access

Review Article published in “Pharmaceutical Medicine”


This review article considers two alternative options to standard treatment for desperately ill patients when standard treatments are no longer working: clinical trials and the Food and Drug Administration’s (FDA’s) expanded access program. The article describes the history of drug regulation in the United States, pointing out that the clinical […]

2019-03-24T17:15:07-04:00March 22, 2019|General|

[Blog Post] Kidney Disease and Colorectal Cancer: To Prevent Health Disparities, Early Detection Is Key

March is National Kidney Month and National Colorectal Cancer Awareness Month. On the surface, these two designations appear to have little in common. In fact, however, like many conditions, kidney disease and colorectal cancer disproportionately affect members of minority populations.

With both conditions, early detection is key. For colorectal cancer, early detection saves lives. Yet many […]

2019-04-16T09:56:06-04:00March 18, 2019|General|

[Guest Post] Compassion and Safety Drive FDA Expanded Access Program

Today’s Food and Drug Administration (FDA) expanded access pathway has its roots in a 1970s decision to make investigational new drugs (INDs) available to some cancer patients who did not qualify for clinical trials. Although no official policy was enacted, FDA allowed the National Cancer Institute (NCI) to distribute “Group C” drugs to oncologists to […]

2019-03-26T19:57:30-04:00March 4, 2019|General|

[Blog Post] Raising Awareness of Rare Diseases

What if your child had a rare disease that threatened to significantly shorten his or her life? That’s the reality for nearly 15 million U.S. children and their families.

Worldwide, more than 300 million people, including 25 million to 30 million Americans, have been diagnosed with a rare disease—a condition defined as affecting fewer than 200,000 […]

2019-02-28T09:07:46-04:00February 28, 2019|General|

[Blog Post] Disparities in Heart Health

The nation’s No. 1 killer is even more deadly for African Americans

February has been designated American Heart Month to help raise awareness that heart disease is the nation’s No. 1 killer.

February also is Black History Month, perhaps the ideal time to call attention to the fact that heart disease can be especially deadly for African […]

2019-04-16T09:58:12-04:00February 19, 2019|General|
Load More Posts